- Accesswire•6 days ago
NEW YORK, NY / ACCESSWIRE / March 17, 2017 / There has been significant interest in both companies by investment rating firms and individual investors over the past quarter. The interest is not necessarily ...
- Motley Fool•7 days ago
Do Adamas Pharmaceuticals and Amicus Therapeutics have the potential to power your portfolio higher?
- GlobeNewswire•14 days ago
CRANBURY, N.J. and MILAN, Italy, March 08, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, has commenced the commercial launch of the precision ...
FOLD : Summary for Amicus Therapeutics, Inc. - Yahoo Finance
Amicus Therapeutics, Inc. (FOLD)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||6.50 x 300|
|Ask||7.35 x 500|
|Day's Range||6.76 - 7.10|
|52 Week Range||4.41 - 9.83|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-4.75|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|